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Abstract — We conducted a pilot study to examine the feasibility, 
acceptability, and preliminary effects of a computer-tailored 
intervention for parents to promote their adolescents’ HPV 
vaccination.  Among 29 parents recruited from clinics (n = 24; 
83%) and the community (21%) who completed intervention and 
pre- and post-intervention assessments, all (100%) intended to 
vaccinate their adolescents aged 11-17 after the intervention. 
Furthermore, all parents recruited from the clinics consented to 
their adolescents receiving the first HPV vaccine, except for one 
parent who wanted to wait until the child turned 13 years old. 
Regarding the theoretical mediators, results of Wilcoxon Signed 
Ranks test suggested significant positive changes in HPV-related 
knowledge and facilitators over time. Nearly all (97%) of the 
parents reported that the intervention helped them make a 
decision about their child’s HPV vaccination and was a good way 
for the parents to learn about HPV and the vaccines. All parents 
stated that they would recommend this intervention to other 
parents who had unvaccinated adolescents.  
Keywords - adolescent health; computerized; tailored 
intervention; health promotion; HPV; vaccine 
I. INTRODUCTION
     Human papilloma virus (HPV) infection is the most 
common sexually transmitted infection in the United States 
and the primary cause of both cervical cancer and genital 
warts. Currently about 79 million Americans are infected with 
HPV, and this number is projected to increase by 14 million 
new cases each year [1]. In addition to the strong relationship 
between HPV Types 16 and 18 in female cervical cancer, 
HPV-associated oropharyngeal cancer has significantly 
increased in men over the past 20 years [2]. HPV vaccines 
have effectively reduced HPV-related cancers and diseases in 
the United States [1] and globally [3]. Thus, it is 
recommended that boys and girls at age 11 or 12 years in the 
United States should receive HPV vaccines [1, 4]. Since 
parents must consent for their adolescents under age 18 to 
receive HPV vaccines [5], it is important to engage them in 
decision-making about vaccinating their adolescents against 
HPV. Thus, our tailored intervention targeted parents with 
unvaccinated adolescents aged 11-17. 
     Empirical evidence [e.g., 6] suggests that multilevel factors 
are associated with the parents’ decision to vaccinate their 
adolescents against HPV. These factors include: (a) individual 
(e.g., lack of knowledge and awareness of HPV and vaccines, 
perceived minimal risk of infection, worry that the vaccination 
encourages an adolescent’s sexual behavior, concerns about 
vaccine safety and effectiveness); (b) interpersonal (e.g., 
provider recommendation); (c) community (e.g., community 
norms on parental responsibility to protect their adolescent 
child); and (d) systemic (e.g., HPV-related messages portrayed 
in social media, state policy, insurance coverage, limited 
access to healthcare) levels. 
     While an empirical understanding of the parents’ decision-
making about HPV vaccination for their adolescent child has 
increased during the last decade, efficacious interventions 
designed to promote HPV vaccination in both adolescent boys 
and girls remain limited. The rapid development of mobile 
technology has opened new and promising avenues for 
researchers and healthcare providers to develop innovative, 
personalized and tailored health education interventions, and 
to disseminate these to a wider population at relatively low 
cost, when compared with traditional interventions that are 
delivered using written materials or trained health educators 
[7]. Compared to non-tailored information/messages, research 
findings suggest that tailored information/messages developed 
to address individual knowledge, beliefs/attitudes, and 
situations are perceived by consumers as more relevant to their 
needs and preferences, thus more effective in prompting 
targeted behaviors [8]. Computer-tailored health education has 
shown promising results in promoting preventive behaviors, 
such as cancer screening [9, 10] and HPV vaccination [11, 
12].  
     Through our previous and current collaborations with 
county vaccine clinics on health promotion projects [11, 13, 
14], we have learned that among parents and adolescents who 
attend the clinics for school-mandated, non-HPV vaccines 
almost all parents and the majority of adolescents own 
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smartphones, and they are very experienced and comfortable 
with mobile technologies. Given that our intervention 
considers the competing demands of healthcare providers 
within clinical settings, and the popularity among parents and 
adolescents in the use of mobile technologies, our brief 
computer-tailored intervention provides an acceptable and 
feasible approach for parents and adolescents to learn about 
HPV and HPV vaccines, and to motivate vaccination behavior 
during  the same visit. 
     In summary, our study aimed to (a) examine the feasibility 
and acceptability of this intervention, and (b) investigate the 
preliminary efficacy of this intervention on parental intentions 
to vaccinate their child, and action to obtain the first HPV 
vaccine.  
II.     METHODS 
A. Design and sample 
We used a one-group, pre- and post-test, quasi-
experimental design.  A parent was recruited if s/he (a) was 18 
years old or older and (b) had one or more children aged 11-17 
years old who had not been vaccinated for HPV. Only one 
parent from each family could participate in this study.  If an 
eligible parent had more than one child ages 11-17 years old 
who had not received the HPV vaccination, we asked the 
parent to answer questions based on the oldest child.  Our 
intervention and study materials were developed in both 
English and Spanish to meet the language needs of participants.  
B. Procedures 
We recruited participants by posting flyers in high-traffic 
areas in one vaccine clinic that serves a predominantly low-
income population, advertising through local community 
organizations, and via word of mouth, approaches proven to be 
effective in recruiting our target population [11, 13, 14]. One 
bilingual (English/Spanish) interventionist was also available at 
the clinic and community organizations to advertise the study 
and screen potential participants. She also explained study 
purpose and procedures to eligible participants and obtained 
the informed consent from them.  Our bilingual interventionist 
demonstrated how to access the intervention and online pretest 
and posttest surveys (T1 & T2) via a touchscreen tablet with a 
wireless data connection. The interventionist also answered 
participants’ questions and noted all additional assistance given 
to them as part of the evaluation.  The entire process, including 
consenting took approximately 30 minutes. Participants 
received $10 for their participation. 
C. Ethical considerations 
We received approval from the Arizona State University 
Institutional Review Board and Maricopa County Department 
of Public Health (MCDPH) prior to executing this project, and 
received informed consent from participants prior to their 
participation.   We collected data via an anonymous survey,  
whereby each participant’s survey was pre-assigned a unique 
numeric code, All data were stored on a HIPAA-compliant 
encrypted server with multilevel password protection, 
enterprise-level firewalls, and antivirus barriers. 
D. Theoretical framework  
Our theoretical framework consisted of an integration of the 
Health Belief Model [15] and the Theory of Planned Behavior 
[16]. These models introduce specific psychosocial constructs 
that aid in modelling processes underlying HPV vaccination 
behaviors. Our intervention delivers messages designed to 
influence these relevant constructs (knowledge, perceived 
risks, perceived barriers, perceived facilitators).  
E. Intervention 
We developed tailored messages using information from 
multiple sources, including focus groups with key informants 
(parents) and healthcare providers. The design of the 
intervention software and the conversation tree for participant 
interaction have been presented elsewhere [13].  
This tailored intervention, delivered via tablet computers, 
demonstrated feasibility, acceptability and preliminary effects 
in increasing parental intent and uptake of first HPV vaccines 
in Mexican American youth [11, 13]. Given the success of our 
original intervention that was designed for a Mexican 
American population, and per the request from the 
collaborating clinics and communities, we modified that 
original intervention towards a “multi-ethnic” intervention that 
can meet the needs of all parents with unvaccinated youth.  
Our intervention included tailored messages that addressed 
(a) knowledge (HPV risk in adolescent boys and girls, HPV’s 
link with different types of cancers and diseases, how to 
prevent HPV, HPV vaccine types, dose and safety issues); (b)  
perceived risks (child's acquisition of HPV infection based on 
child’s age, sex, race/ethnicity, sexual behavior and 
orientation, family history of cancer, signs and symptoms, 
general health or other reasons); (c) facilitators for HPV 
vaccination (e.g., healthcare provider’s suggestions, 
encouragement from religious leaders/pastors, beliefs that 
HPV vaccination will save a child’s life); (d) barriers (e.g., 
lack of health insurance, worry about the safety of the 
vaccines); and (e) cultural norms (e.g., “Being healthy or sick 
is my child’s destiny. I cannot do anything to change it.”). 
 
 
Figure 1. Screen of Provider Avatars 
 
We would also like to thank Institute for Social Science Research at 
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Using the tablet, each participant logged into an account 
with a pre-assigned code, chose a preferred language (English 
or Spanish) and an avatar to represent the provider (from 4 
different avatars; Fig. 1).  The provider avatar spoke, and the 
participant was presented with response options. After the 
participant responded, the provider avatar presented her 
answers via text and speech. 
For example, for a mother with (a) a boy who (b) did not 
have any symptoms and (c) perceived zero risk because “My 
boy is very healthy and does not have any symptoms. He does 
not need the HPV vaccines,” the provider avatar would 
provide a feedback message to address this misconception: 
“Many parents do not feel their children are at risk for human 
papillomavirus (also called HPV) infection because they do 
not see any symptoms. However, many adolescents who 
become infected with HPV do not even know they have it.” 
Participants who did not endorse a particular risk factor would 
not receive a feedback message and would be led to the next 
“perceived risk” option. Figure 2 presents sample images of 
screens seen by participants.  
 
 
   
Figure 2. Example Screens of the Intervention 
 
  The final screen of the intervention presented a resource 
guide with current local and state-level information about 
vaccine clinics and health insurance coverage for participants 
who indicated a need (e.g., “I am not sure if my child is 
eligible for free or discount HPV vaccines.”).   
F. Measures 
We adapted and modified survey questions from existing 
valid and reliable measures, including our prior work [11, 13].  
Feasibility: assessed by parent-reported ease of use, response 
rate (percentage of eligible individuals agreeing to 
participate), and the number of completed assessments.   
Acceptability: measured by a 12-item questionnaire 
developed and tested in our prior research [9, 11, 17, 18] to 
assess participants’ ratings of the appropriateness of the 
content and wording, graphic design and color, clarity of 
directions, length of the program, and likelihood of 
recommending the program to other parents who share the 
same cultural background.  All items used a 4-point Likert-
type scale with response options ranging from strongly 
disagree (1) to strongly agree (4). 
Sociodemographic characteristics: Participants answered 13 
items regarding their own age, sex, race/ethnicity, education, 
employment, religion, and number of children; age(s) and 
sex(es) of their child(ren); whether the child(ren) received 
reduced or free lunch in school, and whether the participant 
received HPV education from other sources.   
HPV-related knowledge: We included 12 true/false 
questions that addressed known risk factors for HPV infection, 
HPV-related diseases, and methods of detection from the 
literature [19], which were modified based on our prior work 
[11, 13].  
Perceived risk: Eight true/false items (e.g., boys will not get 
HPV infection) were used to assess parents’ perceived risks of 
their children being infected with HPV. 
Facilitators: Nine yes/no items corresponding to a list of 
factors reported in prior research [20] to promote HPV 
vaccination behaviors (e.g., healthcare provider’s 
recommendation, positive attitudes toward HPV vaccination) 
were used to assess parents’ perceived facilitators. 
Barriers: Twenty-one yes/no items corresponding to a list of 
perceived barriers reported in previous research [21, 22, 23], 
such as access to HPV vaccines (cost, insurance coverage, 
whether the parent has a regular primary care provider, 
availability of transportation), potential side effects of the 
vaccines, number of required vaccine shots, were used to 
assess parents’ perceived barriers for vaccination.  
Cultural norms: we adapted 3 items from the Cancer 
Screening Fatalism subscale of the Cultural Cancer Screening 
Scale (CCSS) [24] that had adequate reliability and predictive 
validity in women for breast and cervical cancer screening.  
All items used a 5-point Likert-type scale with response 
options ranging from strongly disagree (1) to strongly agree 
(5).  The total score ranges from 3 to 15; lower scores indicate 
more favorable beliefs toward HPV vaccination. 
Intention: Parental behavioral intention to vaccinate their 
children against HPV was assessed with one yes/no item. 
Appointment: One yes/no item assessed whether or not the 
parent had made an appointment for their child’s HPV 
vaccination.  Parents who had not made appointments were 
asked why and probed regarding any factors that may have 
prevented them from doing so. 
Vaccination: One yes/no item was used to assess whether or 
not the target child received the first dose of HPV vaccines. 
F. Data analysis 
Pretest and posttest data collected via online surveys were 
saved and managed using REDCap [25], a secure, web-based 
data collection platform and then imported into SPSS 24.0 
[26] for analysis.  Given the study’s relatively small sample 
size, we conducted univariate analyses (e.g., means, 
frequencies, standard deviations) to describe distributions of 
study variables and Wilcoxon matched-pairs test to examine 
pre-post changes in key variables.  
 
III. RESULTS 
A. Sample characteristics 
     Out of 31 parents enrolled in this study, 29 (93.5%; mean 
age 38.2 years, SD = 7.6) completed the intervention and both 
the T1 and T2 assessments. Of these 29 participants, 24 
(82.8%) were recruited from and completed study activities in 
the clinic; the remainder (n = 5; 17.2%) completed the 
activities in a community setting. The median number of 
children in the household was 4 (range 1-8). Seven (24%) of 
the parents chose Spanish versions of the intervention and 
questionnaires. Detailed information about the sample is 
presented in Table 1. 
  
TABLE 1. Sample Characteristics (N = 29) 
 
Note. $Source of HPV Information before Intervention. The total 
percentage was over 100% as parents could choose more than one  
source of learning HIV information 
B. Feasibility and acceptability 
In this pilot study, feasibility was measured by response 
rate (percentage of eligible individuals agreeing to 
participate), number of participants who completed the 
intervention, and participant-reported ease of use. Of 35 
eligible individuals, 31 (88.6%) agreed to participate in this 
study. Similar to our prior research [11], eligible parents 
declined to participate due to their prescheduled commitments 
(e.g., need to go back to work or pick up other children). 
Among 31 parents who consented to participate, 2 of them 
could not complete posttest (T2) due to the same reasons. 
Although these 2 parents could not complete posttest survey, 
they still consented their adolescent children to receive the 
first HPV vaccine at the clinic.  
All participants reported that the computerized 
intervention was very easy (75.9%) or somewhat easy (24.1%) 
to use and understand; 93.1% said that the intervention was 
able to hold their attention, the content was relevant to their 
lives, and it provided the information they would like to know. 
About 97% of parents reported the tailored intervention helped 
them make a decision about child’s HPV vaccination and was 
a good way for parents to learn about HPV and the vaccines. 
All parents stated that they would recommend this 
intervention to other parents with unvaccinated adolescents.  
Staff in the clinic also shared that the intervention was feasible 
to be implemented, given that it did not add any extra burden 
to their clinical activities.    
Regarding the acceptability of the tailored intervention, the 
mean acceptability score was 3.65 (SD = 0.40, range 1-4). 
C. Theoretical mediators 
     HPV-related knowledge: Findings from Wilcoxon Signed 
Ranks test suggested significant positive change from pre-
intervention (Mdn = 5.5) to post-intervention (Mdn = 8.7); Z = 
- 3.3, p = 0.001.  
     Facilitators: parents perceived significantly more 
facilitators from pre-intervention (Mdn = 9.3) to post-
intervention (Mdn = 10.1, Z = - 2.7, p = 0.007.)  
     Barriers, perceived risks and cultural norms: the difference 
from pre-intervention to post-intervention was not statistically 
significant in these 3 variables.   
D. Vaccination intention and behavior 
     We measured the preliminary effect of the intervention in 
terms of parents’ intention to vaccinate their adolescent 
children and whether or not the adolescent received the first 
dose of HPV vaccine.  
     Intention: After the intervention, 100% (n = 29) of parents, 
recruited from either the clinic or community setting intended 
to get their children vaccinated.  
     Behavior: Among the 24 parents who completed the 
intervention in the clinic, all of them consented to having their 
adolescents receive the first HPV vaccine, except for one 
parent who preferred to wait until the child is 13 years old. 
The 5 parents who completed the intervention in the 
community setting stated that they would make an 
appointment with pediatricians’ offices for HPV vaccination; 
however, the actual behavior was unknown.  
IV. DISCUSSION 
Similar to our prior intervention that targeted only 
Mexican-heritage parents [11], this intervention that was 
designed for all parents regardless of racial/ethnic background, 
demonstrated promising effects. Parent reports indicated that 
the intervention was feasible and acceptable.  The strong 
Variables n % 
Participant’s biological sex   
   Father 6  20.7 
   Mother 23 79.3 
Race/Ethnicity   
   Hispanic/Latino 14 48.4 
   White, non-Hispanic 12 41.4 
   Asian American 1 3.4 
   Black 1 3.4 
   Mixed 1  3.4 
Education attainment   
   High school/GED and above 19 65.5 
   Less than high school diploma 10 34.5 
Employment status   
   Full time ( > = 36 hours per week) 10 34.5 
   Part-time (< 36 hours per week) 5  17.2 
   Not working 14 48.3 
Target child’s biological sex   
  Boy 18 62.1 
  Girl 11 37.9 
Child received free or reduced lunch   
   Yes 19 65.5 
    No 10 34.5 
$Source of learning HPV Information before 
Intervention    
   Heard about HPV from family  0 0.0 
   Heard about HPV from friends & neighbors 0 0.0 
   Heard about HPV from healthcare providers 10 34.5 
   Heard about HPV from my or child’s school 2 6.9 
   Heard about HPV from TV, radio or newspaper 2   6.9 
   Heard about HPV from religious leader 0 0.0 
   Never heard about HPV before intervention 17 58.6 
intention (100%) and high vaccination rate immediately post-
intervention (95.8%) in the clinical sample provided a 
preliminary demonstration of the efficacy of this intervention. 
The qualitative feedback from both parents and adolescents 
also suggested that adolescents were interested in learning 
about this important topic to help them make informed 
decisions about vaccination and their own health. This finding 
was also seen in our other study that targeted adolescents aged 
11-17 [14].  
As suggested by other researchers [e.g., 20], parents 
identified “prevents HPV,” “saves my child’s life,” “knowing 
where to get the vaccine,” “provider’s recommendation,” and 
“affordability” as five primary reasons to facilitate HPV 
vaccination behavior.  The top five barriers reported by 
parents were: “safety concerns about vaccines,” “lack of 
provider’s recommendation,” “my child is too young to get it,” 
“I have no insurance and cannot afford it,” and “I don’t know 
if it works.” These barriers are also consistent with other 
research findings [21, 27, 28, 29, 30].  Our tailored 
intervention addressed identified facilitators (e.g., provider’s 
recommendation, knowing where to get the vaccine, 
affordability) and barriers (e.g., lack of provider’s 
recommendation, cannot afford it) when it was implemented 
in the county walk-in, free clinics. Parents commented on how 
easy and convenient it was for them to learn HPV-related 
knowledge, and on how it motivated them to endorse the first 
HPV shot for their adolescent child while they were at the 
clinic for school-mandated, non-HPV vaccines. For parents 
who completed the intervention in the community setting, they 
appreciated the tailored intervention to help them learn about 
HPV and vaccines, and increase their intention to vaccinate 
their adolescent child. We provided a resource kit to the 
community sample, so under- and un-insured adolescents 
could locate clinics that provide free vaccines.    
Similar to our prior research [11], parents did not identify 
any cultural norms (e.g., “Being healthy or sick is my child’s 
destiny. I cannot do anything to change it.”) related to parents’ 
intention or behavior. Empirical studies [e.g., 31, 32] have 
shown mixed findings about parents’ decision-making for 
HPV vaccination for their adolescent boys vs. girls. Our 
findings indicate that parents, regardless of their 
race/ethnicity, agreed that both adolescent boys and girls 
should be vaccinated against HPV. As indicated in the 
previous section, parents reported that they intended to 
vaccinate their adolescent child because these vaccines 
prevent HPV and can save his/her child’s life. Healthcare 
provider’s recommendation regarding the HPV vaccination 
also motivated parents, consistent with prior findings [11, 20]. 
Our tailored intervention provided a feasible and 
acceptable way for parents to learn about HPV and vaccines 
and to promote communication between parents and providers 
about HPV vaccines. Parents also learned about local and state 
resources for free vaccinations. These features showed 
promising effects in promoting vaccination intent and 
behavior. Furthermore, we developed avatars who represented 
different races/ethnicities based on appearance and skin 
colors. We found that Spanish-speaking Mexican-heritage 
parents tended to choose avatars with an appearance similar to 
their own, consistent with the Social Cognitive Theory 
principles of vicarious identification and learning [33]. While 
parents were completing these research activities, many of 
their adolescent children expressed their interests in learning 
more about HPV and the vaccines since they did not learn the 
information from any other sources. Parents also 
recommended the development of a similar intervention for 
their adolescents, so that adolescents can participate in the 
decision-making process to promote their own wellbeing. 
     There are several limitations to note in this study. The 
small sample size in this pilot study did not allow for 
comparative analysis between the clinic and community 
samples or a more detailed testing of the theoretical model. 
While we were able to track first dose of HPV vaccines for 
adolescents who received it in the clinics immediately after 
their parents completed the intervention, we were not able to 
estimate the actual rates of initiating or completing HPV 
vaccination for those who decided to vaccinate later. As a next 
step, a longitudinal, randomized clinical trial with an adequate 
sample size and a true control/comparison group is needed to 
evaluate the effectiveness of this intervention [34, 35] to 
promote initiation (first dose) and completion (both doses, for 
adolescents younger than 15) of HPV vaccination.  
V. IMPLICATIONS AND CONCLUSION 
The national goal for HPV vaccination is 80% (all doses) 
for boys and girls by age 15 [36].  However, only 43% of 
adolescents (49.5% for girls, 37.5% for boys) were up to date 
on the recommended HPV vaccine doses [37]. The Advisory 
Committee on Immunization Practices (ACIP) has 
recommended a universal HPV vaccination in boys and girls at 
11-12 years to protect against HPV associated cancers. Our 
tailored intervention implemented in clinic and community 
settings show promising results in promoting parents’ intention 
and behavior to vaccinate their adolescents against HPV. This 
intervention proved to be easy to deliver via tablet and highly 
acceptable to parents with limited health literacy. Parents who 
received the intervention at the clinics welcomed this brief 
intervention while waiting for their children to receive other 
school-mandated vaccines (e.g., meningococcal vaccine) and 
liked that they could have the first dose of HPV vaccine 
administered during the same visit rather than having to make 
another appointment. A successful intervention of this nature 
has the potential for broad-based scaling up for a significant 
public health [38] impact on HPV vaccination in other settings.  
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